Medico Reach
AUGUST 18, 2022
Founder: Eric Lefkofsky Year of establishment: 2015 Headquarters: Chicago, Illinois. Tempus began with the goal of incorporating artificial intelligence and data science into the healthcare industry. Now, the organization is looking at opening over 500 to 700 new doctors’ offices in collaboration with Walgreens by 2025.
Contrarian Sales Techniques
APRIL 21, 2022
At the crossroads between marketing and healthcare, MSRs spend their long days traveling to healthcare providers to boost their pharmaceutical companies' "revenues". Doctorate in pharmacy and can earn up to RM8,000 or more, depending on the years of service. You can read more about MR job description.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
JULY 4, 2022
However, as Dr Storf illustrated during the webinar, sharing data through networks of experts and healthcare providers could be a potential solution to this ongoing issue. Currently, records captured in the healthcare settings are comprised of structured and unstructured data, which needs to be comparable or searchable. “It
Medgadget
JULY 19, 2023
HFX was FDA approved in May 2015 for the treatment of chronic back and leg pain, including claims of superiority over traditional SCS treatment. These frequent in-person visits are inconvenient and time consuming for not only the patient but also for their healthcare provider.
European Pharmaceutical Review
DECEMBER 21, 2022
Furthermore, entire value chains must be redesigned and the CO 2 emitters (especially point source emitters), chemical industry and power sector, downstream users, eg, healthcare industries and their customers, and healthcare providers need to be coordinated, informed, sensitised and must work out contractual frameworks to de-risk the investments.
pharmaphorum
OCTOBER 10, 2022
As Krishna details, it is a task that cannot be achieved by siloed pharma and healthcare providers working in isolation. 2015; 24(4): 720–726. Forewarned is forearmed. Reaching for the pinnacle ‘gold standard’ of cancer screening is a complicated task. Cited at: [link] [Last accessed: September 2022. Lyratzopoulos G et al.
Pharmaceutical Technology
JANUARY 6, 2023
In Par and Novartis’ agreement, Par gained exclusive rights to market its generic for six months after Novartis’ period of exclusivity finished, beginning September 30, 2014 and ending March 30, 2015. This is the second time that allegations of Novartis violating the False Claims Act have been dismissed in the last three years.
Expert insights. Personalized for you.
98 
Let's personalize your content